Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Next-generation cancer organoids
Bauer L. LeSavage, Riley A. Suhar, Nicolas Broguière, et al.
Nature Materials (2021) Vol. 21, Iss. 2, pp. 143-159
Closed Access | Times Cited: 306

Showing 1-25 of 306 citing articles:

Embracing cancer complexity: Hallmarks of systemic disease
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 146
Artificial intelligence aids in development of nanomedicines for cancer management
Ping Tan, Xiaoting Chen, Hu Zhang, et al.
Seminars in Cancer Biology (2023) Vol. 89, pp. 61-75
Closed Access | Times Cited: 143
Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine
Sanae El Harane, Bochra Zidi, Nadia El Harane, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1001-1001
Open Access | Times Cited: 65
Spatially controlled construction of assembloids using bioprinting
Julien G. Roth, Lucia G. Brunel, Michelle S. Huang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 62
Tumor heterogeneity: preclinical models, emerging technologies, and future applications
Marco Proietto, Martina Crippa, C. Damiani, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 50
Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment
Elena M. Tosca, Davide Ronchi, Daniele Facciolo, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1058-1058
Open Access | Times Cited: 49
Recent advances in defined hydrogels in organoid research
Zhongqiao Gan, Xinyuan Qin, Haitao Liu, et al.
Bioactive Materials (2023) Vol. 28, pp. 386-401
Open Access | Times Cited: 46
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa T. Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 44
Integrating organoids and organ-on-a-chip devices
Yimu Zhao, Shira Landau, Sargol Okhovatian, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 7, pp. 588-608
Closed Access | Times Cited: 26
Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids
Bauer L. LeSavage, D.H. Zhang, Carla Huerta-López, et al.
Nature Materials (2024) Vol. 23, Iss. 8, pp. 1138-1149
Closed Access | Times Cited: 26
Construction of tumor organoids and their application to cancer research and therapy
Jiajing Lv, Xuan Du, Miaomiao Wang, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1101-1125
Open Access | Times Cited: 19
Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine
Shanqiang Qu, Rongyang Xu, Guozhong Yi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 17
A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments
Yanmei Zhang, Qifan Hu, Yuquan Pei, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Clinical applications of human organoids
Monique M.A. Verstegen, Robert P. Coppes, Anne Béghin, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 9
Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system
Chutong Tian, Shunzhe Zheng, Xinying Liu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 57
Biomaterial-based platforms for tumour tissue engineering
Rodrigo Curvello, Verena Kast, Paloma Ordóñez‐Morán, et al.
Nature Reviews Materials (2023) Vol. 8, Iss. 5, pp. 314-330
Open Access | Times Cited: 39
Dissecting metastasis using preclinical models and methods
Jess D. Hebert, Joel W. Neal, Monte M. Winslow
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 391-407
Closed Access | Times Cited: 39
Calcium silicate nanowires-containing multicellular bioinks for 3D bioprinting of neural-bone constructs
Hongjian Zhang, Qin Chen, Meng Zhang, et al.
Nano Today (2022) Vol. 46, pp. 101584-101584
Closed Access | Times Cited: 38
Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids
Beatriz Subtil, Kirti K. Iyer, Dennis Poel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 38
3D cancer models: One step closer to in vitro human studies
Nicoletta Manduca, Ester Maccafeo, Ruggero De Maria, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 38
Antibody-drug conjugates in breast cancer: overcoming resistance and boosting immune response
Hannah L. Chang, Blake Schwettmann, Heather L. McArthur, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 18
Open Access | Times Cited: 37
The current state and future of T-cell exhaustion research
Edward Jenkins, T Whitehead, Martin Fellermeyer, et al.
Oxford Open Immunology (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 33
In vitro models to study human gut-microbiota interactions: Applications, advances, and limitations
Yuli Qi, Leilei Yu, Fengwei Tian, et al.
Microbiological Research (2023) Vol. 270, pp. 127336-127336
Open Access | Times Cited: 27
Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies
Zhenzhen Zhou, Yuan Pang, Jingyuan Ji, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 1, pp. 18-32
Closed Access | Times Cited: 26
Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity
Yuhua Hu, Feng Shen, Xi Yang, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top